Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Huber

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 21, 2009
Evaluation of ischemia-modified albumin in myocardial infarction and prostatic diseasesAline K Mastella, Rafael N Moresco, Dievan Bisognin da Silva, et al.
JMIR Research Protocols|January 6, 2026
Early life exposures, neurodevelopment, and health outcomes - a study protocol for a birth cohort study in NepalTor A Strand, Maria Averina, Kjersti Sletten Bakken, et al.
Genome Medicine|May 20, 2024
Analysis of 3760 hematologic malignancies reveals rare transcriptomic aberrations of driver genesXueqi Cao, Sandra Huber, Ata Jadid Ahari, et al.
Environmental Science & Technology|April 15, 2010
Indoor contamination with hexabromocyclododecanes, polybrominated diphenyl ethers, and perfluoroalkyl compounds: an important exposure pathway for people?Stuart Harrad, Cynthia A de Wit, Mohamed Abou-Elwafa Abdallah, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2020
ZN148 Is a Modular Synthetic Metallo-β-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens <i>In Vivo</i>Ørjan Samuelsen, Ove Alexander Høgmoen Åstrand, Christopher Fröhlich, et al.
Cell Reports Methods|August 3, 2021
Retrospective cell lineage reconstruction in humans by using short tandem repeatsLiming Tao, Ofir Raz, Zipora Marx, et al.
Leukemia|May 7, 2025
Myelodysplastic neoplasms with ring sideroblasts without SF3B1 mutations in adults: enrichment of germline variants in congenital sideroblastic anemia genesSandra Novoa-Jáuregui, Sandra Huber, Maria Gabarrós-Subirà, et al.
Nature Communications|October 6, 2020
Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latencyMelanie Werner-Klein, Ana Grujovic, Christoph Irlbeck, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 21, 2009
Evaluation of ischemia-modified albumin in myocardial infarction and prostatic diseasesAline K Mastella, Rafael N Moresco, Dievan Bisognin da Silva, et al.
JMIR Research Protocols|January 6, 2026
Early life exposures, neurodevelopment, and health outcomes - a study protocol for a birth cohort study in NepalTor A Strand, Maria Averina, Kjersti Sletten Bakken, et al.
Genome Medicine|May 20, 2024
Analysis of 3760 hematologic malignancies reveals rare transcriptomic aberrations of driver genesXueqi Cao, Sandra Huber, Ata Jadid Ahari, et al.
Environmental Science & Technology|April 15, 2010
Indoor contamination with hexabromocyclododecanes, polybrominated diphenyl ethers, and perfluoroalkyl compounds: an important exposure pathway for people?Stuart Harrad, Cynthia A de Wit, Mohamed Abou-Elwafa Abdallah, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2020
ZN148 Is a Modular Synthetic Metallo-β-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens <i>In Vivo</i>Ørjan Samuelsen, Ove Alexander Høgmoen Åstrand, Christopher Fröhlich, et al.
Cell Reports Methods|August 3, 2021
Retrospective cell lineage reconstruction in humans by using short tandem repeatsLiming Tao, Ofir Raz, Zipora Marx, et al.
Leukemia|May 7, 2025
Myelodysplastic neoplasms with ring sideroblasts without SF3B1 mutations in adults: enrichment of germline variants in congenital sideroblastic anemia genesSandra Novoa-Jáuregui, Sandra Huber, Maria Gabarrós-Subirà, et al.
Nature Communications|October 6, 2020
Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latencyMelanie Werner-Klein, Ana Grujovic, Christoph Irlbeck, et al.
Pageof 11